We are a clinical stage protein manipulation company creating new therapeutics for patients worldwide. Our platform technologies consist of: - Protein-protein interaction blockade which prevents specific disease-causing proteins from interacting with each other; - Protein degradation which harnesses the body's own natural processes to destroy disease causing proteins. By adopting these approaches, we are expanding the scope of new targets for drug development and unlocking the untapped pool of targets that to date have been considered undruggable. Our goal is to develop a new generation of therapeutics for patients that currently have few options, if any, to treat their diseases effectively.
Looking for a particular Primary Peptides employee's phone or email?
The Primary Peptides annual revenue was $5 million in 2026.
Jack Jin is the COO of Primary Peptides.
3 people are employed at Primary Peptides.
Primary Peptides is based in Vancouver, British Columbia.
The NAICS codes for Primary Peptides are [32, 325, 32541, 3254].
The SIC codes for Primary Peptides are [283, 28].